Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)

M. K. Kwok; G. M. Leung; L. Xu; H. F. Tse; T. H. Lam; T. H. So; C. M. Schooling

Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)

M. K. Kwok, G. M. Leung, L. Xu, H. F. Tse, T. H. Lam, T. H. So, C. M. Schooling

Health Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	18-21
Number of pages	4
Journal	Hong Kong Medical Journal
Volume	29
Issue number	4
Publication status	Published - 1 Aug 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{afb2f96fd5bb497d870cb6c7efe7d272,

title = "Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)",

author = "Kwok, {M. K.} and Leung, {G. M.} and L. Xu and Tse, {H. F.} and Lam, {T. H.} and So, {T. H.} and Schooling, {C. M.}",

year = "2023",

month = aug,

day = "1",

language = "English",

volume = "29",

pages = "18--21",

number = "4",

}

TY - JOUR

T1 - Effects of puerarin supplementation on cardiovascular disease risk factors

T2 - a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)

AU - Kwok, M. K.

AU - Leung, G. M.

AU - Xu, L.

AU - Tse, H. F.

AU - Lam, T. H.

AU - So, T. H.

AU - Schooling, C. M.

PY - 2023/8/1

Y1 - 2023/8/1

UR - http://www.scopus.com/inward/record.url?scp=85170486220&partnerID=8YFLogxK

M3 - Article

C2 - 37690802

AN - SCOPUS:85170486220

SN - 1024-2708

VL - 29

SP - 18

EP - 21

JO - Hong Kong Medical Journal

JF - Hong Kong Medical Journal

IS - 4

ER -

Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)

UN SDGs

Other files and links

Cite this